XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Common Stock
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Treasury Stock
Additional Paid in Capital
Equity-Based Compensation
Foreign Currency Translation Adjustment
Unrealized Pension Actuarial Losses, net of tax
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2020 $ 15 $ 1   $ (10,949) $ 446,739 $ 52,183 $ (7,419) $ (17,064) $ (1,390,038) $ (926,532)
Beginning balance (in shares) at Dec. 31, 2020 2,462,111 3,290,050   122,585            
Increase (Decrease) in Stockholders' Equity (Deficit)                    
Net loss                 (39,200) (39,200)
Equity-based compensation           387       387
Foreign currency translation adjustment             100     100
Net realized pension actuarial gains, net of tax               (157)   (157)
Preferred shares converted to Common Stock (in shares) 11,171 (510,681)                
Payment for fractional shares on Reverse Stock Split         (14)         (14)
Payment for fractional shares on Reverse Stock Split (in shares) (272)                  
Issuance of Common Stock from at the market offerings, net of offering costs $ 1       25,079         25,080
Issuance of Common Stock from at the market offerings, net of offering costs (in shares) 486,591                  
Ending balance at Mar. 31, 2021 $ 16 $ 1   $ (10,949) 471,804 52,570 (7,319) (17,221) (1,429,238) (940,336)
Ending balance (in shares) at Mar. 31, 2021 2,959,601 2,779,369   122,585            
Beginning balance at Dec. 31, 2020 $ 15 $ 1   $ (10,949) 446,739 52,183 (7,419) (17,064) (1,390,038) (926,532)
Beginning balance (in shares) at Dec. 31, 2020 2,462,111 3,290,050   122,585            
Increase (Decrease) in Stockholders' Equity (Deficit)                    
Net loss                   (58,567)
Foreign currency translation adjustment                   (1,344)
Net realized pension actuarial gains, net of tax                   (242)
Ending balance at Jun. 30, 2021 $ 17 $ 1   $ (10,949) 489,176 53,163 (8,763) (17,306) (1,448,605) (943,266)
Ending balance (in shares) at Jun. 30, 2021 3,520,464 2,778,111   122,585            
Beginning balance at Dec. 31, 2020 $ 15 $ 1   $ (10,949) 446,739 52,183 (7,419) (17,064) (1,390,038) (926,532)
Beginning balance (in shares) at Dec. 31, 2020 2,462,111 3,290,050   122,585            
Ending balance at Dec. 31, 2021 $ 37 $ 1   $ (10,949) 838,853 56,123 (7,463) (10,946) (1,532,428) (666,772)
Ending balance (in shares) at Dec. 31, 2021 13,259,748 2,778,111   122,585            
Beginning balance at Mar. 31, 2021 $ 16 $ 1   $ (10,949) 471,804 52,570 (7,319) (17,221) (1,429,238) (940,336)
Beginning balance (in shares) at Mar. 31, 2021 2,959,601 2,779,369   122,585            
Increase (Decrease) in Stockholders' Equity (Deficit)                    
Net loss                 (19,367) (19,367)
Equity-based compensation           593       593
Foreign currency translation adjustment             (1,444)     (1,444)
Net realized pension actuarial gains, net of tax               (85)   (85)
Common Stock exchanged for Series B Preferred Stock (in shares) 28 (1,258)                
Issuance of Common Stock from at the market offerings, net of offering costs $ 1       17,372         17,373
Issuance of Common Stock from at the market offerings, net of offering costs (in shares) 560,835                  
Ending balance at Jun. 30, 2021 $ 17 $ 1   $ (10,949) 489,176 53,163 (8,763) (17,306) (1,448,605) (943,266)
Ending balance (in shares) at Jun. 30, 2021 3,520,464 2,778,111   122,585            
Beginning balance at Dec. 31, 2021 $ 37 $ 1   $ (10,949) 838,853 56,123 (7,463) (10,946) (1,532,428) (666,772)
Beginning balance (in shares) at Dec. 31, 2021 13,259,748 2,778,111   122,585            
Increase (Decrease) in Stockholders' Equity (Deficit)                    
Net loss                 (56,956) (56,956)
Equity-based compensation           302       302
Foreign currency translation adjustment             1,477     1,477
Net realized pension actuarial gains, net of tax               308   308
Common Stock exchanged for Series B Preferred Stock $ (2)       2          
Common Stock exchanged for Series B Preferred Stock (in shares) (900,328)   900,328              
Issuance of Common Stock from at the market offerings, net of offering costs $ 24       114,509         114,533
Issuance of Common Stock from at the market offerings, net of offering costs (in shares) 11,814,075                  
Withholding of employee taxes on vested RSUs           (190)       (190)
Common Stock issued for vested RSUs (in shares) 54,360                  
Ending balance at Mar. 31, 2022 $ 59 $ 1   $ (10,949) 953,364 56,235 (5,986) (10,638) (1,589,384) (607,298)
Ending balance (in shares) at Mar. 31, 2022 24,227,855 2,778,111 900,328 122,585            
Beginning balance at Dec. 31, 2021 $ 37 $ 1   $ (10,949) 838,853 56,123 (7,463) (10,946) (1,532,428) (666,772)
Beginning balance (in shares) at Dec. 31, 2021 13,259,748 2,778,111   122,585            
Increase (Decrease) in Stockholders' Equity (Deficit)                    
Net loss                   (136,155)
Foreign currency translation adjustment                   2,610
Net realized pension actuarial gains, net of tax                   1,110
Ending balance at Jun. 30, 2022 $ 91 $ 1   $ (10,949) 1,008,300 56,761 (4,853) (9,836) (1,668,583) (629,068)
Ending balance (in shares) at Jun. 30, 2022 40,259,275 2,778,111 3,029,900 122,585            
Beginning balance at Mar. 31, 2022 $ 59 $ 1   $ (10,949) 953,364 56,235 (5,986) (10,638) (1,589,384) (607,298)
Beginning balance (in shares) at Mar. 31, 2022 24,227,855 2,778,111 900,328 122,585            
Increase (Decrease) in Stockholders' Equity (Deficit)                    
Net loss                 (79,199) (79,199)
Equity-based compensation           528       528
Foreign currency translation adjustment             1,133     1,133
Net realized pension actuarial gains, net of tax               802   802
Dividend declared and paid on Preferred Stock         (1,396)         (1,396)
Common Stock exchanged for Series B Preferred Stock $ (4)       4          
Common Stock exchanged for Series B Preferred Stock (in shares) (2,129,572)   2,129,572              
Issuance of Common Stock from at the market offerings, net of offering costs $ 36       56,328         56,364
Issuance of Common Stock from at the market offerings, net of offering costs (in shares) 18,189,580                  
Withholding of employee taxes on vested RSUs           (2)       (2)
Common Stock issued for vested RSUs (in shares) 2,494                  
Agreed cancellation of Common Stock issued for Director's vested RSUs (in shares) (31,082)                  
Ending balance at Jun. 30, 2022 $ 91 $ 1   $ (10,949) $ 1,008,300 $ 56,761 $ (4,853) $ (9,836) $ (1,668,583) $ (629,068)
Ending balance (in shares) at Jun. 30, 2022 40,259,275 2,778,111 3,029,900 122,585